{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:08:24Z","timestamp":1761512904830},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00198-010-1498-5","type":"journal-article","created":{"date-parts":[[2010,11,26]],"date-time":"2010-11-26T17:09:57Z","timestamp":1290791397000},"page":"2709-2719","source":"Crossref","is-referenced-by-count":61,"title":["Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)"],"prefix":"10.1007","volume":"22","author":[{"given":"A.","family":"Fahrleitner-Pammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. L.","family":"Langdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Karras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6.","family":"Ljunggren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. B.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rajzbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. F.","family":"Lems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,27]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00198-003-1547-4","volume":"15","author":"W Cockerill","year":"2004","unstructured":"Cockerill W, Lunt M, Silman AJ, Cooper C, Lips P, Bhalla AK, Cannata JB, Eastell R, Felsenberg D, Gennari C, Johnell O, Kanis JA, Kiss C, Masaryk P, Naves M, Poor G, Raspe H, Reid DM, Reeve J, Stepan J, Todd C, Woolf AD, O\u2019Neill TW (2004) Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 15:113\u2013119","journal-title":"Osteoporos Int"},{"key":"1498_CR2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00198-007-0488-8","volume":"19","author":"C Cooper","year":"2008","unstructured":"Cooper C, Jakob F, Chinn C, Martin-Mola E, Fardellone P, Adami S, Thalassinos NC, Melo-Gomes J, Torgerson D, Gibson A, Marin F (2008) Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporos Int 19:493\u2013501","journal-title":"Osteoporos Int"},{"key":"1498_CR3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00198-007-0530-x","volume":"19","author":"RM Francis","year":"2008","unstructured":"Francis RM, Aspray TJ, Hide G, Sutcliffe AM, Wilkinson P (2008) Back pain in osteoporotic vertebral fractures. Osteoporos Int 19:895\u2013903","journal-title":"Osteoporos Int"},{"issue":"Suppl 3","key":"1498_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/8756-3282(95)00500-5","volume":"18","author":"DT Gold","year":"1996","unstructured":"Gold DT (1996) The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone 18(Suppl 3):185\u2013189","journal-title":"Bone"},{"key":"1498_CR5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726\u20131733","journal-title":"Osteoporos Int"},{"key":"1498_CR6","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1359\/jbmr.2000.15.7.1384","volume":"15","author":"A Oleksik","year":"2000","unstructured":"Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, Kanis J (2000) Health-related quality of life in postmenopausal women with low BMD with or without prevalent fractures. J Bone Miner Res 15:1384\u20131392","journal-title":"J Bone Miner Res"},{"key":"1498_CR7","first-page":"1551","volume":"34","author":"F Salaffi","year":"2007","unstructured":"Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W, Italian Multicentre Osteoporotic Fracture Study Group (2007) The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 34:1551\u20131560","journal-title":"J Rheumatol"},{"key":"1498_CR8","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/1529-0131(200111)44:11<2611::AID-ART441>3.0.CO;2-N","volume":"44","author":"SL Silverman","year":"2001","unstructured":"Silverman SL, Minshall ME, Shen W, Harper KD, Xie S (2001) The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study. Arthritis Rheum 44:2611\u20132619","journal-title":"Arthritis Rheum"},{"key":"1498_CR9","first-page":"2405","volume":"32","author":"SL Silverman","year":"2005","unstructured":"Silverman SL, Piziak VK, Chen P, Misurski DA, Wagman RB (2005) Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis. J Rheumatol 32:2405\u20132409","journal-title":"J Rheumatol"},{"key":"1498_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s001980070075","volume":"11","author":"JA Cauley","year":"2000","unstructured":"Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11:556\u2013561","journal-title":"Osteoporos Int"},{"key":"1498_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster J-Y, Borgstrom F, Rizzoli R, on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399\u2013428","journal-title":"Osteoporos Int"},{"key":"1498_CR12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"1498_CR13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s001980070097","volume":"11","author":"R Dowd","year":"2000","unstructured":"Dowd R, Recker RR, Heaney RP (2000) Study subjects and ordinary patients. Osteoporos Int 11:533\u2013536","journal-title":"Osteoporos Int"},{"key":"1498_CR14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.amjmed.2008.09.030","volume":"122","author":"SL Silverman","year":"2009","unstructured":"Silverman SL (2009) From randomized controlled trials to observational studies. Am J Med 122:114\u2013120","journal-title":"Am J Med"},{"key":"1498_CR15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00223-009-9299-6","volume":"85","author":"BL Langdahl","year":"2009","unstructured":"Langdahl BL, Rajzbaum G, Jakob F, Karras D, Ljunggren O, Lems WF, Fahrleitner-Pammer A, Walsh JB, Barker C, Kutahov A, Marin F (2009) Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). Calcif Tissue Int 85:484\u2013493","journal-title":"Calcif Tissue Int"},{"key":"1498_CR16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1185\/030079908X261087","volume":"24","author":"G Rajzbaum","year":"2007","unstructured":"Rajzbaum G, Jakob F, Karras D, Ljunggren O, Lems WF, Langdahl BL, Fahrleitner-Pammer A, Walsh JB, Gibson A, Tynan AJ, Marin F (2007) Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting. Curr Med Res Opin 24:377\u2013384","journal-title":"Curr Med Res Opin"},{"key":"1498_CR17","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1016\/S0002-9343(97)90025-5","volume":"103","author":"PD Ross","year":"1997","unstructured":"Ross PD (1997) Clinical consequences of vertebral fractures. Am J Med 103:30S\u201342S","journal-title":"Am J Med"},{"key":"1498_CR18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/clpt.1983.159","volume":"34","author":"K Sriwatanakul","year":"1983","unstructured":"Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G (1983) Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 34:234\u2013239","journal-title":"Clin Pharmacol Ther"},{"key":"1498_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"YY Laing","year":"1986","unstructured":"Laing YY, Zeger SL (1986) Longitudinal data analysis using generalised linear models. Biometrika 73:13\u201322","journal-title":"Biometrika"},{"key":"1498_CR20","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"DW Hosmer Jr","year":"2000","unstructured":"Hosmer DW Jr, Lemershow S (2000) Applied logistic regression, 2nd edn. Wiley, New York","edition":"2"},{"key":"1498_CR21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00198-007-0485-y","volume":"19","author":"S Adami","year":"2008","unstructured":"Adami S, San Martin J, Mu\u00f1oz-Torres M, Econs MJ, Xie L, Dalsky GP, McClung M, Felsenberg D, Brown JP, Brandi ML, Sipos A (2008) Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis. Osteoporos Int 19:87\u201394","journal-title":"Osteoporos Int"},{"key":"1498_CR22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1359\/jbmr.081215","volume":"24","author":"R Eastell","year":"2009","unstructured":"Eastell R, Nickelsen T, Marin F, Barker C, Hadji P, Farrerons J, Audran M, Boonen S, Brixen K, Melo Gomes J, Obermayer-Pietsch B, Avramidis A, Sigurdsson G, Gluer CC (2009) Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS). J Bone Miner Res 24:726\u2013736","journal-title":"J Bone Miner Res"},{"key":"1498_CR23","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/archinte.164.18.2024","volume":"164","author":"R Lindsay","year":"2004","unstructured":"Lindsay R, Scheele WH, Neer R, Pohl G, Adami S, Mautalen C, Reginster J-Y, Stepan JJ, Myers SL, Mitlak BH (2004) Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis. Arch Intern Med 164:2024\u20132030","journal-title":"Arch Intern Med"},{"key":"1498_CR24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1359\/JBMR.050501","volume":"20","author":"R Prince","year":"2005","unstructured":"Prince R, Sipos A, Hossain A, Syversen U, Ish-Shalom S, Marcinowska E, Halse J, Lindsay R, Dalsky GP, Mitlak BH (2005) Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. J Bone Miner Res 20:1507\u20131513","journal-title":"J Bone Miner Res"},{"key":"1498_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-005-2013-2","volume":"17","author":"MC Nevitt","year":"2006","unstructured":"Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH (2006) Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 17:273\u2013280","journal-title":"Osteoporos Int"},{"key":"1498_CR26","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s00198-006-0177-z","volume":"17","author":"MC Nevitt","year":"2006","unstructured":"Nevitt MC, Chen P, Kiel DP, Reginster JY, Dore RK, Zanchetta JR, Glass EV, Krege JH (2006) Reduction in the risk of developing back pain persists at least 30\u00a0months after discontinuation of teriparatide treatment: a meta-analysis. Osteoporos Int 17:1630\u20131637","journal-title":"Osteoporos Int"},{"key":"1498_CR27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0900429","volume":"361","author":"R Buchbinder","year":"2009","unstructured":"Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B (2009) A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 361:557\u2013568","journal-title":"N Engl J Med"},{"key":"1498_CR28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMoa0900563","volume":"361","author":"DF Kallmes","year":"2009","unstructured":"Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, Ralston SH, Jarvik JG (2009) A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 361:569\u2013579","journal-title":"N Engl J Med"},{"key":"1498_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archinte.160.1.77","volume":"160","author":"MC Nevitt","year":"2000","unstructured":"Nevitt MC, Thompson DE, Black DM, Rubin SR, Ensrud K, Yates AJ, Cummings SR, for the Fracture Intervention Trial Research Group (2000) Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Arch Intern Med 160:77\u201385","journal-title":"Arch Intern Med"},{"key":"1498_CR30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10067-004-0881-z","volume":"23","author":"J Iwamoto","year":"2004","unstructured":"Iwamoto J, Takeda T, Sato Y, Uzawa M (2004) Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption and chronic back pain in postmenopausal women with osteoporosis. Clin Rheumatol 23:383\u2013389","journal-title":"Clin Rheumatol"},{"key":"1498_CR31","first-page":"1556","volume":"32","author":"PD Miller","year":"2005","unstructured":"Miller PD, Shergy WJ, Body J-J, Chen P, Rohe ME, Krege JH (2005) Long-term reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. J Rheumatol 32:1556\u20131562","journal-title":"J Rheumatol"},{"key":"1498_CR32","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-004-1798-8","volume":"16","author":"JA Knopp","year":"2005","unstructured":"Knopp JA, Diner BM, Blitz M, Lyritis GP, Rowe BH (2005) Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 16:1281\u20131290","journal-title":"Osteoporos Int"},{"key":"1498_CR33","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00586-005-0899-1","volume":"14","author":"G Papadokstakis","year":"2005","unstructured":"Papadokstakis G, Katonis P, Damilakis J, Hadjipavlou A (2005) Does raloxifene treatment influence back pain and disability among postmenopausal women with osteoporosis? Eur Spine J 14:977\u2013981","journal-title":"Eur Spine J"},{"key":"1498_CR34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00586-005-0916-4","volume":"15","author":"G Papadokostakis","year":"2006","unstructured":"Papadokostakis G, Damilakis J, Mantzouranis E, Katonis P, Hadjipavlou A (2006) The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis. Eur Spine J 15:356\u2013362","journal-title":"Eur Spine J"},{"key":"1498_CR35","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1185\/030079906X154097","volume":"22","author":"S Scharla","year":"2006","unstructured":"Scharla S, Oertel H, Helsberg K, Kessler F, Langer F, Nickelsen T (2006) Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6\u00a0months duration. Curr Med Res Opin 22:2393\u20132402","journal-title":"Curr Med Res Opin"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00198-010-1498-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T16:35:50Z","timestamp":1497890150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1498-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,27]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1498-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,27]]}}}